Filing Details
- Accession Number:
- 0001209191-21-051627
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-16 16:21:39
- Reporting Period:
- 2021-08-12
- Accepted Time:
- 2021-08-16 16:21:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1768446 | Eliem Therapeutics Inc. | ELYM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326628 | Len Blavatnik | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Fl New York NY 10019 | No | No | No | Yes | |
| 1391297 | Access Industries Holdings Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Fl New York NY 10019 | No | No | No | Yes | |
| 1508226 | Access Industries Management, Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | No | Yes | |
| 1871741 | Ai Eti Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Fl New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-12 | 4,209,400 | $0.00 | 4,209,400 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-08-12 | 800,000 | $12.50 | 5,009,400 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Redeemable Convertible Preferred Stock | Disposition | 2021-08-12 | 3,568,375 | $0.00 | 3,568,375 | $0.00 |
| Common Stock | Series B Redeemable Convertible Preferred Stock | Disposition | 2021-08-12 | 641,025 | $0.00 | 641,025 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date.
- The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
- Represents securities purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
